Date | Price Target | Rating | Analyst |
---|---|---|---|
5/30/2024 | Sell → Neutral | Seaport Research Partners | |
2/28/2024 | $17.50 | Neutral → Sell | Seaport Research Partners |
12/14/2023 | Neutral | Seaport Research Partners | |
6/8/2022 | $8.00 | Underperform → Neutral | BofA Securities |
5/23/2022 | $7.00 | Mkt Perform | SVB Leerink |
12/10/2021 | $18.00 → $7.00 | Equal-Weight → Underweight | Morgan Stanley |
12/10/2021 | $33.00 → $12.00 | Buy → Neutral | Goldman Sachs |
12/9/2021 | $30.00 → $20.00 | Market Perform | SVB Leerink |
Seaport Research Partners upgraded Radius Recycling from Sell to Neutral
Seaport Research Partners downgraded Radius Recycling from Neutral to Sell and set a new price target of $17.50
Seaport Research Partners initiated coverage of Radius Recycling with a rating of Neutral
10-Q - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
8-K - RADIUS RECYCLING, INC. (0000912603) (Filer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
4 - RADIUS RECYCLING, INC. (0000912603) (Issuer)
U.S. equities were little moved on Tuesday as investors continued to assess the potential for interest rate cuts following the latest economic data and comments from Fed Chair Jerome Powell. Speaking at the European Central Bank (ECB) forum in Portugal, Powell welcomed recent progress on disinflation and noted that the labor market is “appropriately cooling,” reinforcing market expectations for reduced borrowing costs later this year. He anticipates inflation to be between 2% and 2.5% by this time next year but did not commit to a specific course of action. Powell also highlighted the unsustainable trajectory of the U.S. national debt, labeling it a “top-level issue” for policymakers a
Radius Recycling, Inc. (NASDAQ:RDUS) shares are trading lower after the company reported worse-than-expected third-quarter sales results. Revenue stood at $674 million, missing the consensus of $693.9 million. Ferrous sales volumes (LT, in thousands) decreased to 1,112 from 1,157 a year ago; adjusted EBITDA per ferrous ton sold ($/LT) was $8 compared to $48 in the prior year quarter. Average net ferrous sales prices ($/LT) fell to $350 from $413 last year. Finished steel average net sales price ($/ST) came in at $817 (vs. 924 a year ago), and sales volumes (ST, in thousands) of 126 (vs. 142 in the comparable period). Gross margin declined to $46 million from $96 million a year ag
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company's reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included
PORTLAND, Ore., June 18, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its third quarter fiscal 2024 ended May 31, 2024 on Tuesday, July 2, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Recycling, I
TYMLOS®demonstrated a lower incidence of hip fracture and non-vertebral fracture compared to teriparatide in women with osteoporosis 50 years and older (n=43,352) in this analysis of real-world dataBOSTON, MA / ACCESSWIRE / April 16, 2024 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. ("Radius" or the "Company"), a specialty biopharmaceutical company focused on bone health, presented real-world evidence from an analysis comparing the effectiveness of TYMLOS® (ABL) to teriparatide (TPTD) in women with osteoporosis ages 50 years and older who were new to anabolic therapy (n=43,352). In this analysis of over 18-months of treatment, abaloparatide demonstrated a
Urges Stockholders to Vote "FOR" Radius' Highly Qualified, Independent Director Nominees – Catherine J. Friedman, Jean-Pierre Garnier, Ph.D. and Andrew C. von Eschenbach, M.D. – on the BLUE Proxy Card Details Company's Significant Progress Since 2020, Under Refreshed Board and Management Team BOSTON, June 06, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (NASDAQ:RDUS) today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission ("SEC") for its upcoming Annual Meeting of Stockholders, which will be held online on July 8, 2022. Stockholders of record as of June 3, 2022, will be entitled to vote at the meeting. In c
EMERYVILLE, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (NASDAQ:BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley Lights' Board of Directors as an independent director, effective December 15, 2021. "Dr. Hopfield is a respected and accomplished industry veteran, and we are thrilled to welcome her to our Board," said Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights. "With more than two decades of medical device, biotech and pharmaceutical experience, Dr. Hopfield brings to Berkeley Lights valuable strategic insight and a strong focus on performance to drive our unrivaled ability to understand c
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing. This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capital and Industry Ventures. Dr. Samuel Cohen, Chief Executive Officer of Wren, commented: “This support from both our existing as
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. The Company's reported and adjusted results differed significantly this quarter. Due primarily to a non-cash goodwill impairment charge reflecting the challenging market conditions for recycled metals experienced during the last year, the Company reported a loss per share from continuing operations of $(6.97) and a net loss of $(199) million in the third quarter. These results included
PORTLAND, Ore., June 18, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) announced that the Company will report financial results for its third quarter fiscal 2024 ended May 31, 2024 on Tuesday, July 2, 2024. The Company will host a webcast conference call to discuss the results at 11:30 a.m. Eastern Time on the same day. The webcast of the call and the accompanying slide presentation may be accessed on Radius Recycling's website at www.radiusrecycling.com/company/investors. The call will be hosted by Tamara Lundgren, Chairman and Chief Executive Officer, and Stefano Gaggini, Senior Vice President and Chief Financial Officer. About Radius Recycling, Inc. Radius Recycling, I
Nonferrous and Finished Steel Sales Volumes Up Year-Over-Year Increased Cost Reduction Target by $40 Million Radius Board Declares Quarterly Dividend PORTLAND, Ore., April 04, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ:RDUS) today reported results for the second quarter of fiscal 2024 ended February 29, 2024. The Company reported a loss per share from continuing operations of $(1.19) and a net loss of $(34) million. Adjusted EBITDA was $3 million and adjusted loss per share from continuing operations was $(1.04). Market conditions during the second quarter remained challenging, as tight supply flows for recycled metals and unusually wet winter weathe
SC 13D/A - Radius Health, Inc. (0001428522) (Subject)
SC 13D/A - Radius Health, Inc. (0001428522) (Subject)
SC 13G - Radius Health, Inc. (0001428522) (Subject)
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy
Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Tentative Approval' on 10/28/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy